Precision BioSciences Growth, Revenue, Number of Employees and Funding

Overview

Location:
Durham, NC
Total Funding:$153.3M
Industry:Biotech
Founded:2006
Lead Investor(s):Mulitple
Press

Industry Ranking

Growjo 10k Ranking

Revenue & Financials

  • Precision BioSciences's revenue is currently $10.8M per year.
  • Precision BioSciences received $40.0M in venture funding in March 2019.
  • Precision BioSciences's revenue per employee is $93478
  • Precision BioSciences's total funding is $153.3M.

Employee Data

  • Precision BioSciences has 115 Employees.
  • Precision BioSciences grew their employee count by 19% last year.
  • Precision BioSciences currently has 17 job openings.

What Is Precision BioSciences?

Precision BioSciences is a privately held biotechnology company dedicated to improving lives through its next generation gene editing technology, ARCUS. Precision's cell therapy, gene therapy, and agriculture programs are based on the proprietary ARC endonuclease, which features coordinated target site binding and DNA cutting to ensure precise edits. Our team includes pioneers in genome engineering, biotech business leaders, and a staff of committed Precisioneers. We work together in our beautifully designed, award-winning space in vibrant downtown Durham, NC; a place with great restaurants and museums as well as fantastic housing and schools. Precision provides all employees a sense of purpose, thoughtfully designed laboratory and office spaces, and opportunities to train and grow not to mention plentifully stocked kitchens and benefits like wellness massage. At Precision BioSciences, we are excited to work together toward improving lives by realizing the potential of gene editing.

keywords:Biotechnology,Cleantech,Food & Beverages,Healthcare,Medical Diagnostics,Pharmaceuticals,Wind Power

115

Number of Employees

$10.8M

Revenue (est)

17

Current Jobs

19%

Employee Growth %

$153.3M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Similar Companies

NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
Liquidia Techno...
$10.7M759%
BioCryst Pharma...
$16.9M12111%
Liquidia Techno...
$10.7M759%
BioCryst Pharma...
$16.9M12111%
KBI Biopharma
$89.9M66515%
KBI Biopharma
$89.9M66515%
Precision BioSc...
$10.8M11519%$153.3M
G1 Therapeutics
$7.9M8465%$202.6M
Dova Pharmaceut...
$10.4M12880%$85.1M
BioAgilytix
$41M23336%

Precision BioSciences News

18-Mar-19 - Precision Biosciences prices IPO, looks to raise upwards of $135 million

Precision Biosciences has priced their initial public offering between $15-17 per share, meaning their coming IPO has the potential to make the

18-Mar-19 - Eyeing IPO, Precision Bio raises nearly $40M from 23 investors

DURHAM — Precision BioSciences Inc., which earlier this month filed to raise $100 million in an initial public offering, has raised $39.5 million

18-Mar-19 - Precision BioSciences sets IPO terms

Precision BioSciences sets IPO terms. Mar. 18, 2019 6:50 AM ET |About: Precision BioSciences (DTIL)|By: Douglas W. House, SA News Editor. Precision

Precision BioSciences Funding

DateAmountRoundLead InvestorsReference
2015-05-12$25.6MAvenBioArticle
2018-06-11$88.1MUndisclosedArticle
2018-06-27$110.0MUndisclosedArrowMark PartnersArticle
2019-03-12$40.0MUndisclosedMulitpleArticle

Precision BioSciences Executive Hires

DateNameTitleReference
2015-09-03Gene LiauSVP (Gene Therapy)Article
2017-06-21Fayaz KhaziPresidentArticle
2017-07-11David ThomsonChief Development OfficerArticle

Precision BioSciences New Location/Offices

DateLocationReference
2014-06-13Durham, NCArticle